GreenBone Ortho featured in Milano Finanza for its pioneering work at the intersection of regenerative medicine and space research. The article highlights the launch of the AstroBone experiment to the International Space Station (ISS), where GreenBone’s biomimetic bone graft substitute, b.Bone®, is being evaluated in microgravity conditions to advance the understanding of bone regeneration and osteoporosis.

This milestone represents an important step in the company’s mission to develop innovative solutions for patients with bone defects, while demonstrating how space-based research can accelerate the development of next-generation biomedical technologies on Earth.

We are proud to see our work recognized by Milano Finanza and look forward to sharing the results of the AstroBone mission once the samples return to Earth for analysis later this year.